NAC And PCOS/PMOS: What The Research Reveals About Fertility Support

How Insulin Can Influence Reproductive Hormones

Insulin helps the body use glucose for energy. When someone has insulin resistance, their body needs more insulin to achieve its usual effect.

The paper explains that insulin can work alongside luteinising hormone, or LH, to stimulate androgen production in the ovaries. Androgens include testosterone, which can be elevated in women with PCOS/PMOS.

Insulin can also reduce the production of sex hormone-binding globulin, or SHBG. This protein binds sex hormones in the blood. When there is less SHBG, more androgens may be available to act in the body.

These connections help explain why insulin resistance can affect more than blood sugar. It can also contribute to the hormonal environment that influences follicle development and ovulation.

The authors discuss previous research suggesting NAC may improve insulin sensitivity. This provides part of the rationale for studying NAC, although insulin sensitivity was not an outcome combined in this review’s statistical analysis.

Why Antioxidant Protection Matters

The paper also discusses oxidative stress as a possible contributor to the metabolic and reproductive challenges associated with PCOS/PMOS.

Oxidative stress occurs when potentially damaging molecules outweigh the body’s antioxidant defences. The authors describe how this imbalance may contribute to insulin resistance and affect the environment in which ovarian follicles develop.

NAC helps the body produce glutathione, an antioxidant that protects cells from damage. Its antioxidant activity, alongside its potential anti-inflammatory effects, is one reason researchers are interested in its role in reproductive health.

This broadens the focus beyond individual hormone levels. Researchers are also considering the conditions that support cells, tissues and ovarian function.

NAC Was Associated With Higher Progesterone

Across four studies, the combined analysis found higher progesterone levels in women receiving NAC than in the comparison groups.

Progesterone normally rises after ovulation, when the follicle that released the egg becomes the corpus luteum, a temporary structure that produces progesterone.

This hormone helps prepare the uterine lining for a possible pregnancy. Its rise is therefore an important part of the cycle and a relevant measure when investigating reproductive function.

The reported increase gives researchers a reason to explore NAC’s role further. The size of the effect varied considerably between studies, so it remains uncertain how consistently women might experience this benefit.

Some Comparisons Found A Thicker Uterine Lining

The endometrium is the lining inside the uterus, where an embryo would implant if pregnancy occurs.

Fertility research often focuses on ovulation, but the uterine environment matters too. The review examined whether NAC influenced endometrial thickness, a measurement used when assessing the lining.

Women receiving NAC had a thicker uterine lining compared with placebo and certain other treatment groups. There was no clear difference compared with metformin, and combining all comparison groups did not show a statistically significant benefit.

These findings suggest a possible role in particular treatment settings, including situations where a thin lining is a concern. Thickness is only one aspect of the uterine environment, so the finding needs to be considered alongside other measures of reproductive health.

The Results Point To Specific Areas Of Support

NAC’s effects were not the same across all the hormones measured.

The review found no clear differences in total testosterone, estradiol, FSH or SHBG. These measures relate to androgen activity, ovarian function and the availability of sex hormones.

LH was higher with NAC compared with metformin, but not clearly different compared with placebo or other treatments. Because LH activity can already be altered in PCOS/PMOS, a higher level is not automatically an improvement.

The main analyses also did not establish a clear increase in follicle numbers.

Taken together, the results suggest that progesterone and the uterine lining are more useful areas of interest from this review than a general claim of improved “hormone balance.”

Why The Same Approach May Not Work For Everyone

The authors discuss several factors that could influence how women respond to NAC, including differences in metabolic health, age, body composition and PCOS characteristics.

Treatment duration and the use of other medications may also matter. Some studies examined NAC alone, while others added it to fertility or metabolic treatments.

This is relevant because PCOS/PMOS can present differently from one woman to another. Even among women experiencing difficulties with ovulation, the contributing factors and treatment needs may differ.

The authors suggest that future research should explore which groups are most likely to benefit, including women with insulin resistance or greater oxidative stress. These are proposed directions for research, rather than groups this review definitively identified as responders.

What Does This Mean For PCOS/PMOS?

This paper helps explain why researchers are exploring NAC within the wider picture of PCOS/PMOS. Insulin function, androgen activity, oxidative stress and reproductive health are connected, making it useful to investigate approaches that may influence more than one process.

The review’s positive findings centre on progesterone and uterine lining thickness in certain comparisons. Its discussion of antioxidant protection and insulin sensitivity provides context for understanding those results.

The authors see potential for NAC as an additional support alongside established care. Further research can help clarify when it is useful, who is most likely to benefit and how changes in these measurements translate into reproductive outcomes.